{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:44:34Z","timestamp":1790361874657,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04773-x","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:16:04Z","timestamp":1775805364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Poorly differentiated clusters surpass tumor budding as novel prognostic factors in pancreatic cancer, especially in cases treated with neoadjuvant chemotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Daiki","family":"Uchihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Shimajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariza","family":"Nuratdinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"5","key":"4773_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164(5):752\u201365.","journal-title":"Gastroenterology"},{"key":"4773_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311.","journal-title":"Cancer Lett"},{"issue":"7","key":"4773_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4773_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<154::AID-PATH603>3.0.CO;2-C","volume":"191","author":"J L\u00fcttges","year":"2000","unstructured":"L\u00fcttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Kl\u00f6ppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000;191(2):154\u201361.","journal-title":"J Pathol"},{"issue":"1","key":"4773_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1245\/s10434-022-12566-1","volume":"30","author":"N Ikenaga","year":"2023","unstructured":"Ikenaga N, Miyasaka Y, Ohtsuka T, Nakata K, Adachi T, Eguchi S, et al. A prospective multicenter phase II trial of neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancer with arterial involvement. Ann Surg Oncol. 2023;30(1):193\u2013202.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4773_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, et al. Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol. 2019;49(2):190\u20134.","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"4773_CR7","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479\u2013516.","journal-title":"Ann Oncol"},{"issue":"2","key":"4773_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/PAS.0000000000000113","volume":"38","author":"H Ueno","year":"2014","unstructured":"Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Tanaka M, Miyake O, et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol. 2014;38(2):197\u2013204.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4773_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/PAS.0b013e318235edee","volume":"36","author":"H Ueno","year":"2012","unstructured":"Ueno H, Kajiwara Y, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, et al. New criteria for histologic grading of colorectal cancer. Am J Surg Pathol. 2012;36(2):193\u2013201.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4773_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","volume":"30","author":"A Lugli","year":"2017","unstructured":"Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299\u2013311.","journal-title":"Mod Pathol"},{"issue":"5","key":"4773_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ejca.2012.10.022","volume":"49","author":"E Karamitopoulou","year":"2013","unstructured":"Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, et al. Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer. 2013;49(5):1032\u20139.","journal-title":"Eur J Cancer"},{"issue":"1","key":"4773_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74067-z","volume":"10","author":"Y Matsuda","year":"2020","unstructured":"Matsuda Y, Ohkubo S, Nakano-Narusawa Y, Fukumura Y, Hirabayashi K, Yamaguchi H, et al. Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems. Sci Rep. 2020;10(1):18278.","journal-title":"Sci Rep"},{"issue":"1","key":"4773_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53801-2","volume":"9","author":"S Okubo","year":"2019","unstructured":"Okubo S, Kojima M, Matsuda Y, Hioki M, Shimizu Y, Toyama H, et al. Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma. Sci Rep. 2019;9(1):17145.","journal-title":"Sci Rep"},{"issue":"8","key":"4773_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.pan.2021.09.006","volume":"21","author":"A Kameyama","year":"2021","unstructured":"Kameyama A, Ye J, Shimomura A, Yokohira M, Nakano-Narusawa Y, Yamakawa K, et al. Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma. Pancreatology. 2021;21(8):1506\u201315.","journal-title":"Pancreatology"},{"issue":"1","key":"4773_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/MPA.0b013e3182236442","volume":"41","author":"Y Murata","year":"2012","unstructured":"Murata Y, Mizuno S, Kishiwada M, Hamada T, Usui M, Sakurai H, et al. Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4. Pancreas. 2012;41(1):130\u20136.","journal-title":"Pancreas"},{"issue":"2","key":"4773_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/his.12732","volume":"68","author":"LK Fischer","year":"2016","unstructured":"Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, et al. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology. 2016;68(2):210\u201320.","journal-title":"Histopathology"},{"issue":"1","key":"4773_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.radonc.2015.01.004","volume":"114","author":"T Hirata","year":"2015","unstructured":"Hirata T, Teshima T, Nishiyama K, Ogawa K, Otani K, Kawaguchi Y, et al. Histopathological effects of preoperative chemoradiotherapy for pancreatic cancer: an analysis for the impact of radiation and gemcitabine doses. Radiother Oncol. 2015;114(1):122\u20137.","journal-title":"Radiother Oncol"},{"issue":"11","key":"4773_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jhbp.12056","volume":"31","author":"M Ishida","year":"2024","unstructured":"Ishida M, Fujii T, Kishiwada M, Shibuya K, Satoi S, Ueno M, et al. Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition. J Hepatobiliary Pancreat Sci. 2024;31(11):755\u201368.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"4773_CR19","doi-asserted-by":"publisher","unstructured":"JavedAA, Habib JR, Andel PCM, Campbell BA, Rompen IF, Mahmud O, Fatimi A, van Goor I, Schouten TJ, Stoop TF et al: Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication. Ann Surg. 2025. https:\/\/doi.org\/10.1097\/SLA.0000000000006660.","DOI":"10.1097\/SLA.0000000000006660"},{"issue":"6","key":"4773_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00428-014-1580-z","volume":"464","author":"V Barresi","year":"2014","unstructured":"Barresi V, Branca G, Ieni A, Reggiani Bonetti L, Baron L, Mondello S, et al. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch. 2014;464(6):655\u201362.","journal-title":"Virchows Arch"},{"issue":"6","key":"4773_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/PAT.0000000000000300","volume":"47","author":"V Barresi","year":"2015","unstructured":"Barresi V, Bonetti LR, Bettelli S. KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases. Pathology. 2015;47(6):551\u20136.","journal-title":"Pathology"},{"issue":"3","key":"4773_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/his.13242","volume":"71","author":"L Reggiani Bonetti","year":"2017","unstructured":"Reggiani Bonetti L, Lionti S, Domati F, Pagliani G, Mattioli E, Barresi V. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy. Histopathology. 2017;71(3):393\u2013405.","journal-title":"Histopathology"},{"issue":"6","key":"4773_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/PAS.0000000000001059","volume":"42","author":"T Konishi","year":"2018","unstructured":"Konishi T, Shimada Y, Lee LH, Cavalcanti MS, Hsu M, Smith JJ, et al. Poorly differentiated clusters predict colon cancer recurrence: an in-depth comparative analysis of invasive-front prognostic markers. Am J Surg Pathol. 2018;42(6):705\u201314.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4773_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23928","volume":"10","author":"E Ibuki","year":"2024","unstructured":"Ibuki E, Kadota K, Kimura N, Ishikawa R, Oshima M, Okano K, et al. Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy. Heliyon. 2024;10(1):e23928.","journal-title":"Heliyon"},{"issue":"1","key":"4773_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cncr.26243","volume":"118","author":"JS Estrella","year":"2012","unstructured":"Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, et al. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer. 2012;118(1):268\u201377.","journal-title":"Cancer"},{"issue":"1","key":"4773_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.stem.2014.11.001","volume":"16","author":"S Puri","year":"2015","unstructured":"Puri S, Folias AE, Hebrok M. Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease. Cell Stem Cell. 2015;16(1):18\u201331.","journal-title":"Cell Stem Cell"},{"key":"4773_CR27","doi-asserted-by":"crossref","unstructured":"Marstrand-Dauc\u00e9 L, Lorenzo D, Chassac A, Nicole P, Couvelard A, Haumaitre C: Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer. Int J Mol Sci. 2023;24(12):9946.","DOI":"10.3390\/ijms24129946"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04773-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:52:55Z","timestamp":1779069175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4773"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04773-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"His retrospective study, conducted at a single center, received approval from the Ethics Committee of University of occupational and environmental health (protocol no. CR24-016). All procedures conformed to the ethical standards of the Declaration of Helsinki. Written informed consent was obtained from all participants, and an opt-out mechanism was provided to ensure adequate notification and allow patients to decline the use of their clinical information via our institutional website.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}